Abstract
BackgroundThe NADPH redox cycle plays a key role in antioxidant protection of human erythrocytes. It consists of two enzymes: glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase. Over 160 G6PD variants have been characterized and associated with several distinct clinical manifestations. However, the mechanistic link between the genotype and the phenotype remains poorly understood.Methodology/Principal FindingsWe address this issue through a novel framework (design space) that integrates information at the genetic, biochemical and clinical levels. Our analysis predicts three qualitatively-distinct phenotypic regions that can be ranked according to fitness. When G6PD variants are analyzed in design space, a correlation is revealed between the phenotypic region and the clinical manifestation: the best region with normal physiology, the second best region with a pathology, and the worst region with a potential lethality. We also show that Plasmodium falciparum, by induction of its own G6PD gene in G6PD-deficient erythrocytes, moves the operation of the cycle to a region of the design space that yields robust performance.Conclusions/SignificanceIn conclusion, the design space for the NADPH redox cycle, which includes relationships among genotype, phenotype and environment, illuminates the function, design and fitness of the cycle, and its phenotypic regions correlate with the organism's clinical status.
Highlights
The NADPH redox cycle plays a key role in the oxidative stress response of human erythrocytes
These results show that local performance in Systemic Regime a fulfills all the criteria defined above
The local behavior of the NADPH redox cycle can be evaluated according to the seven criteria described in the METHODS section and our aim is to distinguish among the several classes of glucose-6-phosphate dehydrogenase (G6PD) variants (Table 5)
Summary
The NADPH redox cycle plays a key role in the oxidative stress response of human erythrocytes It consists of two enzymes: glucose-6-phosphate dehydrogenase (G6PD, EC 1.1.1.49) and glutathione reductase (GSR, EC 1.8.1.7). Variants of G6PD have been intensively studied and are associated with several distinct clinical manifestations, the relationship between the genotype and the phenotype is still poorly understood. To address this issue, we have constructed a ‘‘system design space’’ which facilitates the quantitative comparison of wild-type and variants for the redox cycle. The NADPH redox cycle plays a key role in antioxidant protection of human erythrocytes It consists of two enzymes: glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase. The mechanistic link between the genotype and the phenotype remains poorly understood
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
